Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Partial Epithelial-to-Mesenchymal Transition and Other New Mechanisms of Kidney Fibrosis
Sara Lovisa, Michael Zeisberg, Raghu Kalluri
Trends in Endocrinology and Metabolism (2016) Vol. 27, Iss. 10, pp. 681-695
Closed Access | Times Cited: 216

Showing 1-25 of 216 citing articles:

Targeting the progression of chronic kidney disease
Marta Ruíz-Ortega, Sandra Rayego‐Mateos, Santiago Lamas, et al.
Nature Reviews Nephrology (2020) Vol. 16, Iss. 5, pp. 269-288
Closed Access | Times Cited: 703
TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
Evangelia Pardali, Gonzalo Sánchez‐Duffhues, Maria Catalina Gomez‐Puerto, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 10, pp. 2157-2157
Open Access | Times Cited: 309
Pathophysiological implications of hypoxia in human diseases
Pai‐Sheng Chen, Wen‐Tai Chiu, Pei‐Ling Hsu, et al.
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 229
The fibrogenic niche in kidney fibrosis: components and mechanisms
Li Li, Haiyan Fu, Youhua Liu
Nature Reviews Nephrology (2022) Vol. 18, Iss. 9, pp. 545-557
Closed Access | Times Cited: 226
Epithelial–mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease
Mohit Kumar Jolly, Chris Ward, Mathew Suji Eapen, et al.
Developmental Dynamics (2017) Vol. 247, Iss. 3, pp. 346-358
Open Access | Times Cited: 222
A Metabolic Basis for Endothelial-to-Mesenchymal Transition
Jianhua Xiong, Hiroyuki Kawagishi, Ye Yan, et al.
Molecular Cell (2018) Vol. 69, Iss. 4, pp. 689-698.e7
Open Access | Times Cited: 213
New Insights Into the Role and Mechanism of Partial Epithelial-Mesenchymal Transition in Kidney Fibrosis
Lili Sheng, Shougang Zhuang
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 188
Metabolic regulation of dermal fibroblasts contributes to skin extracellular matrix homeostasis and fibrosis
Xiao Zhao, Pamela Psarianos, Laleh Soltan Ghoraie, et al.
Nature Metabolism (2018) Vol. 1, Iss. 1, pp. 147-157
Closed Access | Times Cited: 177
Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists
Agata Winiarska, Monika Knysak, Katarzyna Nabrdalik, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10822-10822
Open Access | Times Cited: 125
Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la/KLF5 pathway
Xuanxuan Zhang, Jicong Chen, Ruohui Lin, et al.
Redox Biology (2024) Vol. 75, pp. 103246-103246
Open Access | Times Cited: 25
LOX-induced tubulointerstitial fibrosis via the TGF-β/LOX/Snail axis in diabetic mice
Yicheng Lu, Heyangzi Li, Mohan Chen, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Runt-Related Transcription Factor 1 (RUNX1) Promotes TGF-β-Induced Renal Tubular Epithelial-to-Mesenchymal Transition (EMT) and Renal Fibrosis through the PI3K Subunit p110δ
Tong Zhou, Maocai Luo, Wei Cai, et al.
EBioMedicine (2018) Vol. 31, pp. 217-225
Open Access | Times Cited: 138
The metabolic syndrome and chronic kidney disease
Xin Zhang, Lilach O. Lerman
Translational research (2016) Vol. 183, pp. 14-25
Open Access | Times Cited: 124
Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression
Li Gao, Xiang Zhong, Juan Jin, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 92
Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics
David Dolivo, Pamela J. Weathers, Tanja Dominko
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 2, pp. 322-339
Open Access | Times Cited: 87
Cellular Origin and Functional Relevance of Collagen I Production in the Kidney
Simone Buchtler, Alexandra Grill, Stefanie Hofmarksrichter, et al.
Journal of the American Society of Nephrology (2018) Vol. 29, Iss. 7, pp. 1859-1873
Open Access | Times Cited: 85
Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases
José Luis Morgado‐Pascual, Sandra Rayego‐Mateos, Lucía Tejedor-Santamaría, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 83
Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer
Julienne L. Carstens, Sujuan Yang, Pedro Corrêa de Sampaio, et al.
Cell Reports (2021) Vol. 35, Iss. 2, pp. 108990-108990
Open Access | Times Cited: 71
Epithelial–mesenchymal transition in organ fibrosis development: current understanding and treatment strategies
Lexin Liu, Qizhe Sun, Frank M. Davis, et al.
Burns & Trauma (2022) Vol. 10
Open Access | Times Cited: 61
Sirtuin 7 mitigates renal ferroptosis, fibrosis and injury in hypertensive mice by facilitating the KLF15/Nrf2 signaling
Xueting Li, Jiawei Song, Zhen-Zhou Zhang, et al.
Free Radical Biology and Medicine (2022) Vol. 193, pp. 459-473
Closed Access | Times Cited: 60
Inhibition of S100A8/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy
Lei Du, Yibing Chen, Jiasen Shi, et al.
Metabolism (2022) Vol. 144, pp. 155376-155376
Closed Access | Times Cited: 44
Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization
Xun Zhou, Hui Chen, Yan Hu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 33
Mechanisms of kidney fibrosis and routes towards therapy
N. Yamashita, Rafael Kramann
Trends in Endocrinology and Metabolism (2023) Vol. 35, Iss. 1, pp. 31-48
Closed Access | Times Cited: 32
Oxidatively stressed extracellular microenvironment drives fibroblast activation and kidney fibrosis
Li Li, Meizhi Lu, Yiling Peng, et al.
Redox Biology (2023) Vol. 67, pp. 102868-102868
Open Access | Times Cited: 30
m6A eraser FTO modulates autophagy by targeting SQSTM1/P62 in the prevention of canagliflozin against renal fibrosis
Youjing Yang, Qianmin Li, Yi Ling, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top